On May 8, 2009 the University of Massachusetts Medical School’s Center for Stem Cell Biology and Regenerative Medicine and Tongi University School and Medicine in Shanghai China entered into a cooperative partnership to support mutual beneficial goals within stem cell biology and regenerative medicine.
This agreement allows Tongi to register many, if not all, of the its human pluripotent stem cells lines on the International Stem Cell Registry developed and operated by UMMS. UMMS will work with Tongi to develop a stem cell registry for human pluripotent stem cell lines created in China.
Tongi has also agreed to deposit a number of its human pluripotent stem cell lines into the Massachusetts Human Stem Cell Bank. With all the necessary licenses and material transfer agreements in provided by Tongi, so the bank can distribute these lines to interested parties outside Asia.
The agreement calls upon UMMS will assist Tongi in developing educational and training, operational protocols, and setting up a training laboratory. In addition, the agreement establishes a framework for collaborative research efforts between investigators at each institution.